Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Costall

Showing results (251-260 of 294) with videos related to

Pageof 30
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1990
Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stemJ M Barnes, N M Barnes, B Costall, et al.
Neuropharmacology|July 1, 1987
Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: behavioural correlates in rodent and primateJ C Barnes, N J Barnes, N M Barnes, et al.
Neuropharmacology|August 1, 1986
The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitorsA J Bradbury, B Costall, P G Jenner, et al.
Neuropharmacology|August 1, 1986
MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal areaA J Bradbury, B Costall, P G Jenner, et al.
Psychopharmacology|January 1, 1987
The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic functionS R Hirsch, R Richardson-Andrews, B Costall, et al.
Journal of Neural Transmission. Supplementum|January 1, 1986
Neuropharmacological manipulations with MPTPN J Barnes, A J Bradbury, B Costall, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1990
Sites of action of ondansetron to inhibit withdrawal from drugs of abuseB Costall, B J Jones, M E Kelly, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1990
Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuseB Costall, B J Jones, M E Kelly, et al.
European Journal of Pharmacology|August 6, 1991
Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's diseaseN M Barnes, C H Cheng, B Costall, et al.
Neuroscience Letters|July 31, 1985
The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatmentA J Bradbury, B Costall, P G Jenner, et al.
Pageof 30

Showing results (251-260 of 294) with videos related to

Sort By:
Pageof 30
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1990
Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stemJ M Barnes, N M Barnes, B Costall, et al.
Neuropharmacology|July 1, 1987
Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: behavioural correlates in rodent and primateJ C Barnes, N J Barnes, N M Barnes, et al.
Neuropharmacology|August 1, 1986
The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitorsA J Bradbury, B Costall, P G Jenner, et al.
Neuropharmacology|August 1, 1986
MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal areaA J Bradbury, B Costall, P G Jenner, et al.
Psychopharmacology|January 1, 1987
The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic functionS R Hirsch, R Richardson-Andrews, B Costall, et al.
Journal of Neural Transmission. Supplementum|January 1, 1986
Neuropharmacological manipulations with MPTPN J Barnes, A J Bradbury, B Costall, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1990
Sites of action of ondansetron to inhibit withdrawal from drugs of abuseB Costall, B J Jones, M E Kelly, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1990
Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuseB Costall, B J Jones, M E Kelly, et al.
European Journal of Pharmacology|August 6, 1991
Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's diseaseN M Barnes, C H Cheng, B Costall, et al.
Neuroscience Letters|July 31, 1985
The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatmentA J Bradbury, B Costall, P G Jenner, et al.
Pageof 30